APO Research
Talk to an analyst

APO RESEARCH · REPORT

NAD+ Enhancer

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global NAD+ Enhancer Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

27 December 2025198 pages

Choose your research edition.

Industry ResearchNAD+ Enhancer Industry Research Report 2026125 pages · $2,950 USDIndustry Growth & TrendsGlobal NAD+ Enhancer Industry Growth and Trends Forecast to 2032109 pages · $3,450 USDMarket StructureGlobal NAD+ Enhancer Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal NAD+ Enhancer Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal NAD+ Enhancer Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global NAD+ Enhancer market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for NAD+ Enhancer is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for NAD+ Enhancer is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for NAD+ Enhancer is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for NAD+ Enhancer is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of NAD+ Enhancer include EffePharm, Mirailab Bioscience Inc. (Shinkowa Pharmaceutical), GeneHarbor, NOMON Co., Ltd. (Teijin), Maac10 Formulas, Kingdomway, Herbalmax, Genex Formulas and EZZ, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global NAD+ Enhancer market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of NAD+ Enhancer and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents NAD+ Enhancer sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the NAD+ Enhancer market size, projected growth trends, production technologies, key applications, and end-use industries.

NAD+ Enhancer Segment by Company

EffePharm

Mirailab Bioscience Inc. (Shinkowa Pharmaceutical)

GeneHarbor

NOMON Co., Ltd. (Teijin)

Maac10 Formulas

Kingdomway

Herbalmax

Genex Formulas

EZZ

Elysium Health

Chromadex

CELFULL

Bontac

NAD+ Enhancer Segment by Type

Content ＜98%

Content ≥98%

NAD+ Enhancer Segment by Application

Health Care Products

ClinicsBeauty Products

Others

NAD+ Enhancer Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global NAD+ Enhancer market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of NAD+ Enhancer and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of NAD+ Enhancer.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the NAD+ Enhancer market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of NAD+ Enhancer manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of NAD+ Enhancer in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of NAD+ Enhancer in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. NAD+ Enhancer Industry Trends Table 2. NAD+ Enhancer Industry Drivers Table 3. NAD+ Enhancer Industry Opportunities and Challenges Table 4. NAD+ Enhancer Industry Restraints Table 5. Global NAD+ Enhancer Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global NAD+ Enhancer Revenue Market Share by Manufacturers (2021-2026) Table 7. Global NAD+ Enhancer Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global NAD+ Enhancer Sales Market Share by Manufacturers Table 9. Global NAD+ Enhancer Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global NAD+ Enhancer Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global NAD+ Enhancer Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global NAD+ Enhancer Manufacturers, Product Type & Application Table 13. Global NAD+ Enhancer Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global NAD+ Enhancer by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Content ＜98% Table 17. Major Manufacturers of Content ≥98% Table 18. Global NAD+ Enhancer Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global NAD+ Enhancer Sales by Type (2021-2026) & (K Units) Table 20. Global NAD+ Enhancer Sales by Type (2027-2032) & (K Units) Table 21. Global NAD+ Enhancer Sales Market Share by Type (2021-2026) Table 22. Global NAD+ Enhancer Sales Market Share by Type (2027-2032) Table 23. Global NAD+ Enhancer Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global NAD+ Enhancer Revenue by Type (2021-2026) & (K Units) Table 25. Global NAD+ Enhancer Revenue by Type (2027-2032) & (K Units) Table 26. Global NAD+ Enhancer Revenue Market Share by Type (2021-2026) Table 27. Global NAD+ Enhancer Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Health Care Products Table 29. Major Manufacturers of ClinicsBeauty Products Table 30. Major Manufacturers of Others Table 31. Global NAD+ Enhancer Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 32. Global NAD+ Enhancer Sales by Application (2021-2026) & (K Units) Table 33. Global NAD+ Enhancer Sales by Application (2027-2032) & (K Units) Table 34. Global NAD+ Enhancer Sales Market Share by Application (2021-2026) Table 35. Global NAD+ Enhancer Sales Market Share by Application (2027-2032) Table 36. Global NAD+ Enhancer Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 37. Global NAD+ Enhancer Revenue by Application (2021-2026) & (K Units) Table 38. Global NAD+ Enhancer Revenue by Application (2027-2032) & (K Units) Table 39. Global NAD+ Enhancer Revenue Market Share by Application (2021-2026) Table 40. Global NAD+ Enhancer Revenue Market Share by Application (2027-2032) Table 41. Global NAD+ Enhancer Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 42. Global NAD+ Enhancer Sales by Region (2021-2026) & (K Units) Table 43. Global NAD+ Enhancer Sales Market Share by Region (2021-2026) Table 44. Global NAD+ Enhancer Sales Forecasted by Region (2027-2032) & (K Units) Table 45. Global NAD+ Enhancer Sales Forecasted Market Share by Region (2027-2032) Table 46. North America NAD+ Enhancer Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 47. North America NAD+ Enhancer Sales by Country (2021-2026) & (K Units) Table 48. North America NAD+ Enhancer Sales by Country (2027-2032) & (K Units) Table 49. Europe NAD+ Enhancer Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 50. Europe NAD+ Enhancer Sales by Country (2021-2026) & (K Units) Table 51. Europe NAD+ Enhancer Sales by Country (2027-2032) & (K Units) Table 52. Asia Pacific NAD+ Enhancer Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. Asia Pacific NAD+ Enhancer Sales by Country (2021-2026) & (K Units) Table 54. Asia Pacific NAD+ Enhancer Sales by Country (2027-2032) & (K Units) Table 55. South America, Middle East and Africa NAD+ Enhancer Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. South America, Middle East and Africa NAD+ Enhancer Sales by Country (2021-2026) & (K Units) Table 57. South America, Middle East and Africa NAD+ Enhancer Sales by Country (2027-2032) & (K Units) Table 58. Global NAD+ Enhancer Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global NAD+ Enhancer Revenue by Region (2021-2026) & (US$ Million) Table 60. Global NAD+ Enhancer Revenue by Region (2027-2032) & (US$ Million) Table 61. Global NAD+ Enhancer Revenue Market Share by Region (2021-2026) Table 62. Global NAD+ Enhancer Revenue Market Share by Region (2027-2032) Table 63. EffePharm Company Information Table 64. EffePharm Business Overview Table 65. EffePharm NAD+ Enhancer Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. EffePharm NAD+ Enhancer Product Portfolio Table 67. EffePharm Recent Development Table 68. Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) Company Information Table 69. Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) Business Overview Table 70. Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) NAD+ Enhancer Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) NAD+ Enhancer Product Portfolio Table 72. Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) Recent Development Table 73. GeneHarbor Company Information Table 74. GeneHarbor Business Overview Table 75. GeneHarbor NAD+ Enhancer Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. GeneHarbor NAD+ Enhancer Product Portfolio Table 77. GeneHarbor Recent Development Table 78. NOMON Co., Ltd. (Teijin) Company Information Table 79. NOMON Co., Ltd. (Teijin) Business Overview Table 80. NOMON Co., Ltd. (Teijin) NAD+ Enhancer Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. NOMON Co., Ltd. (Teijin) NAD+ Enhancer Product Portfolio Table 82. NOMON Co., Ltd. (Teijin) Recent Development Table 83. Maac10 Formulas Company Information Table 84. Maac10 Formulas Business Overview Table 85. Maac10 Formulas NAD+ Enhancer Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Maac10 Formulas NAD+ Enhancer Product Portfolio Table 87. Maac10 Formulas Recent Development Table 88. Kingdomway Company Information Table 89. Kingdomway Business Overview Table 90. Kingdomway NAD+ Enhancer Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Kingdomway NAD+ Enhancer Product Portfolio Table 92. Kingdomway Recent Development Table 93. Herbalmax Company Information Table 94. Herbalmax Business Overview Table 95. Herbalmax NAD+ Enhancer Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Herbalmax NAD+ Enhancer Product Portfolio Table 97. Herbalmax Recent Development Table 98. Genex Formulas Company Information Table 99. Genex Formulas Business Overview Table 100. Genex Formulas NAD+ Enhancer Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Genex Formulas NAD+ Enhancer Product Portfolio Table 102. Genex Formulas Recent Development Table 103. EZZ Company Information Table 104. EZZ Business Overview Table 105. EZZ NAD+ Enhancer Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. EZZ NAD+ Enhancer Product Portfolio Table 107. EZZ Recent Development Table 108. Elysium Health Company Information Table 109. Elysium Health Business Overview Table 110. Elysium Health NAD+ Enhancer Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Elysium Health NAD+ Enhancer Product Portfolio Table 112. Elysium Health Recent Development Table 113. Chromadex Company Information Table 114. Chromadex Business Overview Table 115. Chromadex NAD+ Enhancer Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. Chromadex NAD+ Enhancer Product Portfolio Table 117. Chromadex Recent Development Table 118. CELFULL Company Information Table 119. CELFULL Business Overview Table 120. CELFULL NAD+ Enhancer Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 121. CELFULL NAD+ Enhancer Product Portfolio Table 122. CELFULL Recent Development Table 123. Bontac Company Information Table 124. Bontac Business Overview Table 125. Bontac NAD+ Enhancer Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 126. Bontac NAD+ Enhancer Product Portfolio Table 127. Bontac Recent Development Table 128. Key Raw Materials Table 129. Raw Materials Key Suppliers Table 130. NAD+ Enhancer Distributors List Table 131. NAD+ Enhancer Customers List Table 132. Research Programs/Design for This Report Table 133. Authors List of This Report Table 134. Secondary Sources Table 135. Primary Sources List of Figures Figure 1. NAD+ Enhancer Product Image Figure 2. Global NAD+ Enhancer Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global NAD+ Enhancer Market Size (2021-2032) & (US$ Million) Figure 4. Global NAD+ Enhancer Sales (2021-2032) & (K Units) Figure 5. Global NAD+ Enhancer Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 NAD+ Enhancer Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Content ＜98% Image Figure 9. Content ≥98% Image Figure 10. Global NAD+ Enhancer Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global NAD+ Enhancer Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global NAD+ Enhancer Sales Market Share by Type (2021-2032) Figure 13. Global NAD+ Enhancer Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global NAD+ Enhancer Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global NAD+ Enhancer Revenue Market Share by Type (2021-2032) Figure 16. Health Care Products Image Figure 17. ClinicsBeauty Products Image Figure 18. Others Image Figure 19. Global NAD+ Enhancer Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global NAD+ Enhancer Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global NAD+ Enhancer Sales Market Share by Application (2021-2032) Figure 22. Global NAD+ Enhancer Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global NAD+ Enhancer Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global NAD+ Enhancer Revenue Market Share by Application (2021-2032) Figure 25. North America NAD+ Enhancer Sales and Growth Rate (2021-2032) & (K Units) Figure 26. North America NAD+ Enhancer Sales Market Share by Country (2021-2032) Figure 27. U.S. NAD+ Enhancer Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Canada NAD+ Enhancer Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Mexico NAD+ Enhancer Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe NAD+ Enhancer Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe NAD+ Enhancer Sales Market Share by Country (2021-2032) Figure 32. Germany NAD+ Enhancer Sales and Growth Rate (2021-2032) & (K Units) Figure 33. France NAD+ Enhancer Sales and Growth Rate (2021-2032) & (K Units) Figure 34. U.K. NAD+ Enhancer Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Italy NAD+ Enhancer Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Netherlands NAD+ Enhancer Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific NAD+ Enhancer Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific NAD+ Enhancer Sales Market Share by Country (2021-2032) Figure 39. China NAD+ Enhancer Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Japan NAD+ Enhancer Sales and Growth Rate (2021-2032) & (K Units) Figure 41. South Korea NAD+ Enhancer Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Southeast Asia NAD+ Enhancer Sales and Growth Rate (2021-2032) & (K Units) Figure 43. India NAD+ Enhancer Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Australia NAD+ Enhancer Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa NAD+ Enhancer Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa NAD+ Enhancer Sales Market Share by Country (2021-2032) Figure 47. Brazil NAD+ Enhancer Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South Africa NAD+ Enhancer Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Saudi Arabia NAD+ Enhancer Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Turkey NAD+ Enhancer Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Argentina NAD+ Enhancer Sales and Growth Rate (2021-2032) & (K Units) Figure 52. UAE NAD+ Enhancer Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Egypt NAD+ Enhancer Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Chile NAD+ Enhancer Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Global NAD+ Enhancer Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global NAD+ Enhancer Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America NAD+ Enhancer Revenue (2021-2032) & (US$ Million) Figure 58. North America NAD+ Enhancer Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe NAD+ Enhancer Revenue (2021-2032) & (US$ Million) Figure 60. Europe NAD+ Enhancer Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific NAD+ Enhancer Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific NAD+ Enhancer Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa NAD+ Enhancer Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa NAD+ Enhancer Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. NAD+ Enhancer Value Chain Figure 66. Manufacturing Cost Structure Figure 67. NAD+ Enhancer Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Content ＜98%
  • Content ≥98%
Applications
  • Health Care Products
  • ClinicsBeauty Products
  • Others
Companies covered
  • EffePharm
  • Mirailab Bioscience Inc. (Shinkowa Pharmaceutical)
  • GeneHarbor
  • NOMON Co., Ltd. (Teijin)
  • Maac10 Formulas
  • Kingdomway
  • Herbalmax
  • Genex Formulas
  • EZZ
  • Elysium Health
  • Chromadex
  • CELFULL
  • Bontac

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global NAD+ Enhancer Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global NAD+ Enhancer Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global NAD+ Enhancer Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global NAD+ Enhancer Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global NAD+ Enhancer Market Dynamics
  1. 2.1 NAD+ Enhancer Industry Trends
  2. 2.2 NAD+ Enhancer Industry Drivers
  3. 2.3 NAD+ Enhancer Industry Opportunities and Challenges
  4. 2.4 NAD+ Enhancer Industry Restraints
3 NAD+ Enhancer Market by Manufacturers
  1. 3.1 Global NAD+ Enhancer Revenue by Manufacturers (2021-2026)
  2. 3.2 Global NAD+ Enhancer Sales by Manufacturers (2021-2026)
  3. 3.3 Global NAD+ Enhancer Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global NAD+ Enhancer Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global NAD+ Enhancer Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global NAD+ Enhancer Manufacturers, Product Type & Application
  7. 3.7 Global NAD+ Enhancer Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global NAD+ Enhancer Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 NAD+ Enhancer Players Market Share by Revenue in 2025
  11. 3.8.3 2025 NAD+ Enhancer Tier 1, Tier 2, and Tier 3
4 NAD+ Enhancer Market by Type
  1. 4.1 NAD+ Enhancer Type Introduction
  2. 4.1.1 Content ＜98%
  3. 4.1.2 Content ≥98%
  4. 4.2 Global NAD+ Enhancer Sales by Type
  5. 4.2.1 Global NAD+ Enhancer Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global NAD+ Enhancer Sales by Type (2021-2032)
  7. 4.2.3 Global NAD+ Enhancer Sales Market Share by Type (2021-2032)
  8. 4.3 Global NAD+ Enhancer Revenue by Type
  9. 4.3.1 Global NAD+ Enhancer Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global NAD+ Enhancer Revenue by Type (2021-2032)
  11. 4.3.3 Global NAD+ Enhancer Revenue Market Share by Type (2021-2032)
5 NAD+ Enhancer Market by Application
  1. 5.1 NAD+ Enhancer Application Introduction
  2. 5.1.1 Health Care Products
  3. 5.1.2 ClinicsBeauty Products
  4. 5.1.3 Others
  5. 5.2 Global NAD+ Enhancer Sales by Application
  6. 5.2.1 Global NAD+ Enhancer Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global NAD+ Enhancer Sales by Application (2021-2032)
  8. 5.2.3 Global NAD+ Enhancer Sales Market Share by Application (2021-2032)
  9. 5.3 Global NAD+ Enhancer Revenue by Application
  10. 5.3.1 Global NAD+ Enhancer Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global NAD+ Enhancer Revenue by Application (2021-2032)
  12. 5.3.3 Global NAD+ Enhancer Revenue Market Share by Application (2021-2032)
6 Global NAD+ Enhancer Sales by Region
  1. 6.1 Global NAD+ Enhancer Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global NAD+ Enhancer Sales by Region (2021-2032)
  3. 6.2.1 Global NAD+ Enhancer Sales by Region (2021-2026)
  4. 6.2.2 Global NAD+ Enhancer Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America NAD+ Enhancer Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America NAD+ Enhancer Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe NAD+ Enhancer Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe NAD+ Enhancer Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific NAD+ Enhancer Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific NAD+ Enhancer Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa NAD+ Enhancer Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa NAD+ Enhancer Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global NAD+ Enhancer Revenue by Region
  1. 7.1 Global NAD+ Enhancer Revenue by Region
  2. 7.1.1 Global NAD+ Enhancer Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global NAD+ Enhancer Revenue by Region (2021-2026)
  4. 7.1.3 Global NAD+ Enhancer Revenue by Region (2027-2032)
  5. 7.1.4 Global NAD+ Enhancer Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America NAD+ Enhancer Revenue (2021-2032)
  8. 7.2.2 North America NAD+ Enhancer Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe NAD+ Enhancer Revenue (2021-2032)
  11. 7.3.2 Europe NAD+ Enhancer Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific NAD+ Enhancer Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific NAD+ Enhancer Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa NAD+ Enhancer Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa NAD+ Enhancer Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 EffePharm
  2. 8.1.1 EffePharm Company Information
  3. 8.1.2 EffePharm Business Overview
  4. 8.1.3 EffePharm NAD+ Enhancer Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 EffePharm NAD+ Enhancer Product Portfolio
  6. 8.1.5 EffePharm Recent Developments
  7. 8.2 Mirailab Bioscience Inc. (Shinkowa Pharmaceutical)
  8. 8.2.1 Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) Company Information
  9. 8.2.2 Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) Business Overview
  10. 8.2.3 Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) NAD+ Enhancer Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) NAD+ Enhancer Product Portfolio
  12. 8.2.5 Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) Recent Developments
  13. 8.3 GeneHarbor
  14. 8.3.1 GeneHarbor Company Information
  15. 8.3.2 GeneHarbor Business Overview
  16. 8.3.3 GeneHarbor NAD+ Enhancer Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 GeneHarbor NAD+ Enhancer Product Portfolio
  18. 8.3.5 GeneHarbor Recent Developments
  19. 8.4 NOMON Co., Ltd. (Teijin)
  20. 8.4.1 NOMON Co., Ltd. (Teijin) Company Information
  21. 8.4.2 NOMON Co., Ltd. (Teijin) Business Overview
  22. 8.4.3 NOMON Co., Ltd. (Teijin) NAD+ Enhancer Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 NOMON Co., Ltd. (Teijin) NAD+ Enhancer Product Portfolio
  24. 8.4.5 NOMON Co., Ltd. (Teijin) Recent Developments
  25. 8.5 Maac10 Formulas
  26. 8.5.1 Maac10 Formulas Company Information
  27. 8.5.2 Maac10 Formulas Business Overview
  28. 8.5.3 Maac10 Formulas NAD+ Enhancer Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Maac10 Formulas NAD+ Enhancer Product Portfolio
  30. 8.5.5 Maac10 Formulas Recent Developments
  31. 8.6 Kingdomway
  32. 8.6.1 Kingdomway Company Information
  33. 8.6.2 Kingdomway Business Overview
  34. 8.6.3 Kingdomway NAD+ Enhancer Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Kingdomway NAD+ Enhancer Product Portfolio
  36. 8.6.5 Kingdomway Recent Developments
  37. 8.7 Herbalmax
  38. 8.7.1 Herbalmax Company Information
  39. 8.7.2 Herbalmax Business Overview
  40. 8.7.3 Herbalmax NAD+ Enhancer Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Herbalmax NAD+ Enhancer Product Portfolio
  42. 8.7.5 Herbalmax Recent Developments
  43. 8.8 Genex Formulas
  44. 8.8.1 Genex Formulas Company Information
  45. 8.8.2 Genex Formulas Business Overview
  46. 8.8.3 Genex Formulas NAD+ Enhancer Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Genex Formulas NAD+ Enhancer Product Portfolio
  48. 8.8.5 Genex Formulas Recent Developments
  49. 8.9 EZZ
  50. 8.9.1 EZZ Company Information
  51. 8.9.2 EZZ Business Overview
  52. 8.9.3 EZZ NAD+ Enhancer Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 EZZ NAD+ Enhancer Product Portfolio
  54. 8.9.5 EZZ Recent Developments
  55. 8.10 Elysium Health
  56. 8.10.1 Elysium Health Company Information
  57. 8.10.2 Elysium Health Business Overview
  58. 8.10.3 Elysium Health NAD+ Enhancer Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Elysium Health NAD+ Enhancer Product Portfolio
  60. 8.10.5 Elysium Health Recent Developments
  61. 8.11 Chromadex
  62. 8.11.1 Chromadex Company Information
  63. 8.11.2 Chromadex Business Overview
  64. 8.11.3 Chromadex NAD+ Enhancer Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Chromadex NAD+ Enhancer Product Portfolio
  66. 8.11.5 Chromadex Recent Developments
  67. 8.12 CELFULL
  68. 8.12.1 CELFULL Company Information
  69. 8.12.2 CELFULL Business Overview
  70. 8.12.3 CELFULL NAD+ Enhancer Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 CELFULL NAD+ Enhancer Product Portfolio
  72. 8.12.5 CELFULL Recent Developments
  73. 8.13 Bontac
  74. 8.13.1 Bontac Company Information
  75. 8.13.2 Bontac Business Overview
  76. 8.13.3 Bontac NAD+ Enhancer Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Bontac NAD+ Enhancer Product Portfolio
  78. 8.13.5 Bontac Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 NAD+ Enhancer Value Chain Analysis
  2. 9.1.1 NAD+ Enhancer Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 NAD+ Enhancer Production Mode & Process
  6. 9.2 NAD+ Enhancer Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 NAD+ Enhancer Distributors
  9. 9.2.3 NAD+ Enhancer Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst